Anti-diabetic Activity of Phloretin Against Maltase-glucoamylase Using Docking, Pharmacokinetics and Pharmacophore Studies

A metabolic condition known as diabetes mellitus is characterized by hyperglycemia brought on by either inadequate insulin production, resistance to insulin action, or both. The anti-diabetic medications that are now on the market either impact how much glucose is absorbed and excreted or how much i...

Full description

Saved in:
Bibliographic Details
Main Authors: Miah Roney, Mohd Fadhlizil Fasihi Mohd Aluwi
Format: Article
Language:English
Published: Iranian Chemical Science and Technologies Association 2023-10-01
Series:Journal of Chemistry Letters
Subjects:
Online Access:https://www.jchemlett.com/article_180463_a98d8d21bd62de90ef55db0f9a0c099f.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849704356187734016
author Miah Roney
Mohd Fadhlizil Fasihi Mohd Aluwi
author_facet Miah Roney
Mohd Fadhlizil Fasihi Mohd Aluwi
author_sort Miah Roney
collection DOAJ
description A metabolic condition known as diabetes mellitus is characterized by hyperglycemia brought on by either inadequate insulin production, resistance to insulin action, or both. The anti-diabetic medications that are now on the market either impact how much glucose is absorbed and excreted or how much insulin is secreted without affecting insulin resistance. This study used in-silico methods to assess the efficacy of phloretin as anti-diabetic drug against maltase-glucoamylase. Phloretin displayed strong binding to the maltase-glucoamylase protein with good docking scores (-7.4 kcal/mol), as opposed to co-crystallized ligand (-6.2 kcal/mol). In terms of physicochemical qualities, drug-likeness, and medicinal chemistry properties, Phloretin also performed best. The results of molecular docking and data acquired from pharmacokinetic characteristics of phloretin may be used further for the creation of newer maltase-glucoamylases with potential anti-diabetic properties and improved pharmacokinetic profiles.
format Article
id doaj-art-af03f5b5e66e4728aba1f497708d0ce0
institution DOAJ
issn 2821-0123
2717-1892
language English
publishDate 2023-10-01
publisher Iranian Chemical Science and Technologies Association
record_format Article
series Journal of Chemistry Letters
spelling doaj-art-af03f5b5e66e4728aba1f497708d0ce02025-08-20T03:16:46ZengIranian Chemical Science and Technologies AssociationJournal of Chemistry Letters2821-01232717-18922023-10-014316417010.22034/jchemlett.2023.411216.1131180463Anti-diabetic Activity of Phloretin Against Maltase-glucoamylase Using Docking, Pharmacokinetics and Pharmacophore StudiesMiah Roney0Mohd Fadhlizil Fasihi Mohd Aluwi1Faculty of Industrial Sciences and Technology, Universiti Malaysia Pahang Al-Sultan Abdullah, Gambang-26300, Kuantan, Pahang, MalaysiaFaculty of Industrial Sciences and Technology, Universiti Malaysia Pahang Al-Sultan Abdullah, Gambang (26300), Kuantan, Pahang, MalaysiaA metabolic condition known as diabetes mellitus is characterized by hyperglycemia brought on by either inadequate insulin production, resistance to insulin action, or both. The anti-diabetic medications that are now on the market either impact how much glucose is absorbed and excreted or how much insulin is secreted without affecting insulin resistance. This study used in-silico methods to assess the efficacy of phloretin as anti-diabetic drug against maltase-glucoamylase. Phloretin displayed strong binding to the maltase-glucoamylase protein with good docking scores (-7.4 kcal/mol), as opposed to co-crystallized ligand (-6.2 kcal/mol). In terms of physicochemical qualities, drug-likeness, and medicinal chemistry properties, Phloretin also performed best. The results of molecular docking and data acquired from pharmacokinetic characteristics of phloretin may be used further for the creation of newer maltase-glucoamylases with potential anti-diabetic properties and improved pharmacokinetic profiles.https://www.jchemlett.com/article_180463_a98d8d21bd62de90ef55db0f9a0c099f.pdfin-silicodockingpharmacophore
spellingShingle Miah Roney
Mohd Fadhlizil Fasihi Mohd Aluwi
Anti-diabetic Activity of Phloretin Against Maltase-glucoamylase Using Docking, Pharmacokinetics and Pharmacophore Studies
Journal of Chemistry Letters
in-silico
docking
pharmacophore
title Anti-diabetic Activity of Phloretin Against Maltase-glucoamylase Using Docking, Pharmacokinetics and Pharmacophore Studies
title_full Anti-diabetic Activity of Phloretin Against Maltase-glucoamylase Using Docking, Pharmacokinetics and Pharmacophore Studies
title_fullStr Anti-diabetic Activity of Phloretin Against Maltase-glucoamylase Using Docking, Pharmacokinetics and Pharmacophore Studies
title_full_unstemmed Anti-diabetic Activity of Phloretin Against Maltase-glucoamylase Using Docking, Pharmacokinetics and Pharmacophore Studies
title_short Anti-diabetic Activity of Phloretin Against Maltase-glucoamylase Using Docking, Pharmacokinetics and Pharmacophore Studies
title_sort anti diabetic activity of phloretin against maltase glucoamylase using docking pharmacokinetics and pharmacophore studies
topic in-silico
docking
pharmacophore
url https://www.jchemlett.com/article_180463_a98d8d21bd62de90ef55db0f9a0c099f.pdf
work_keys_str_mv AT miahroney antidiabeticactivityofphloretinagainstmaltaseglucoamylaseusingdockingpharmacokineticsandpharmacophorestudies
AT mohdfadhlizilfasihimohdaluwi antidiabeticactivityofphloretinagainstmaltaseglucoamylaseusingdockingpharmacokineticsandpharmacophorestudies